Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques

By Aggarwal A.   Schneider D.J.   Terrien E.F.   Sobel B.E.   Dauerman H.L.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 6-9

Elsevier

Access to resources Recommend Favorite

Influence of Interleukin-10 on the Interleukin-1 Receptor Antagonist/Interleukin-1β Ratio in the Colonic Mucosa of Ulcerative Colitis

By  

Digestion, Vol. 63, Iss. 1, 2001-01 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Gene therapy with the interleukin-1 receptor antagonist for the treatment of arthritis

By Evans Christopher H   Ghivizzani Steven C   Wehling Peter   Robbins Paul D  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 173-178

Future Medicine

Access to resources Recommend Favorite

Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 5, 2001-07 ,pp. : 314-317

Karger

Access to resources Recommend Favorite

Relevance of Interleukin-1 Receptor Antagonist Intron-2 Polymorphism in Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 15, Iss. 4, 2003-04 ,pp. : 276-281

Karger

Access to resources Recommend Favorite